Prevalence of Prolonged QRS Duration and Associated Factors among Heart Failure Patients in a Tertiary Healthcare Facility in Bayelsa State

Authors

  • Okoro E Tamaraemumoemi Department of Internal Medicine, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa, Nigeria. Author
  • Jumbo Johnbull Department of Internal Medicine, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa, Nigeria. Author

Keywords:

Relationship, NYHA class, Ejection fraction, QRS duration, Heart failure

Abstract

Background: Prolonged QRS duration, low ejection fraction and low NYHA class are all independent poor prognostic indices in patients with heart failure. We assessed the prevalence of prolonged QRS duration and it's relationship with ejection fraction and NYHA class, among patients with heart failure at Niger Delta University Teaching Hospital, Okolobiri, Nigeria.

Methods: Eighty three patients diagnosed with heart failure were recruited consecutively. NYHA class was determined at presentation. Electrocardiography and echocardiography were done to determine the QRS duration and ejection fraction respectively.

Results: The prevalence of prolonged QRS was 33.7%. Most of the participants had QRS duration less than 120ms (66.3%), were classified as NYHA class 4 (48.2%) and had a diagnosis of hypertensive heart disease (57.8%). Sixty two patients (74.7%) had ejection fraction <45%. 2 Ejection fraction showed a statistically significant relationship with prolonged QRS duration (X = 10.55; p – 0.001). Other factors such as age, sex, NYHA classification, BMI and blood pressure were not significantly related to prolonged QRS duration in this population.

Conclusion: Over a third of patients in heart failure had QRS prolongation and there was a significant relationship between prolonged QRS duration and systolic dysfunction. Given these findings, appropriate screening of patients with heart failure is suggested to detect QRS prolongation and other ECG abnormalities, in order to adequately intervene and reduce risks of
cardiovascular mortality.

Downloads

Download data is not yet available.

References

1. Adebayo SO, Olunuga TO, Durodola A, Ogah OS. Heart failure: Definition, classification, and pathophysiology – A mini-review. Nig J Cardiol 2017;14:9-14

2. Savarese G, Lund LH.Global Public Health Burden of Heart Failure. Cardiac Failure Review 2017; 3(1):7–11.

3. Adebayo SO, Olunuga TO, Durodola A, Ogah OS. Heart failure: Definition, classification, and pathophysiology – A mini-review. Nig J Cardiol 2017;14:9-14

4. Agbor VN, Essouma M, Ntusi NAB, Nyaga Bigna NoubiapUF , JJ, JJ. Heart failure in sub-Saharan Africa: A contemporaneous systematic review and meta-analysis. Int J Cardiol 2018; 257:207-15

5. Kang S-H, Oh II-Y, Kang Do-Y, Cha M-J, Cho Y, Choi E-K, et al. Cardiac Resynchronization Therapy and QRS Duration: Systematic Review, Meta-analysis, and Meta-regression. Korean Med Sci 2015; 30: 24-33

6. Joseph J, Claggett BC, Anand IS, Fleg JL, Huynh T, Desai AS, et al. QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure 2016; 4 (6): 477-486.

7. Hong JA, Kim MS, Park H, Lee SE, Lee HY, Cho HJ, et al. Prognostic Value of QRS Duration among Patients with Cardiogenic Shock Complicating Acute Heart Failure: Data from the Korean Acute Heart Failure (KorAHF) Registry. Int J Heart Fail. 2020 ;2(2):121-130

8. Reinier K, Narayanan K, Uy-Evanado A, Teodorescu Chugh MackC, H, WJ et al. Electrocardiographic markers and the left ventricular ejection fraction have cumulative effects on risk of sudden cardiac death. J Am Coll Cardiol EP 2015; 1:542–50.

9. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009; 53:e1–e90.

10. Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, et al. Congestive Heart Failure and QRS Duration. Chest2002;

122; 528-534

11. Ramírez ML, Abi-rezk MN, Liriano HM, Sardiñas JG, Barbeito TT, Álvarez JV. QRS duration and its relationship with the postoperative mortality of the coronary artery bypass grafting surgery. CorSalud 2018;10(1):4-12

12. Lund LH, Jurga J, Edner M, Benson L, Dahlstro U, Linde C et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. EurHeart Jour 2013; 34: 29–539

13. Kirchhof P, Breithardt G, Eckardt L. Primary prevention of sudden cardiac death. Heart 2006; 92:1873–1878.

14. Kish L. Survey Sampling. New York. John Wiley and Sons;1965

15. The WHO STEPwise approach to Surveillance of non-communicable diseases (STEPS);2018. Available from: http://www.who.int/chp/steps/en. Accessed July 31, 2018.

16. JNC 7. National High Blood Pressure Education Program. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206–1252.

17. Klingfield P, Gettes LS, Bailey JJ, Childers R, Deal BJ, Hancock W et al. American Heart Committee Report: Recommendation for standardization and interpretation of electrocardiogram. J Am Coll Cardiol 2007; 49: 1109-1127.

18. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, et al; ESC Committee for Practice Guidelines. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace. 2010; 12:1526–1536.

19. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. JASE 2015; Volume 28; Number 1

20. Ho KL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham study. J. Am Coll Cardiol. 1993; 22 (SUPPLA): 6A-13A.

21. American Heart Association. Classes of Heart Failure. Available at http://www.heart.org/HEARTORG/Conditions/HeartFailure/Classes-of-

heart-failure_UCM_306328_Article.jsp#WUcGf-vyuHs. Updated May 8, 2017. Accessed June 18, 2017.

22. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46:2183-92.

23. Akintunde AA. Fragmented QRS and other depolarization abnormalities in Nigerians with heart failure: Prevalence and clinical correlates. Curr Res Cardiol 2015; 2(3):105-108.

24. Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP, et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002; 86:225-31.

25. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol 2004; 93:244-6.

26. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–33

27. Shah MK, Bhalla V, Nwakile C, De Venecia TA, Patil S, Curet K, et al. QRS duration and Left Ventricular Ejection Fraction in Non ST Segment Elevation Myocardial Infarction. JACC 2015; 65(10S):1

28. Bode-Schnurbus L, Böcker D, Block M, Gradaus R, Heinecke A, Breithardt G, et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heartfailure. Heart 2003;89:1157–1162

29. Ogah OS, Sliwa K, Akinyemi JO, Falase AO, Stewart S. Hypertensive Heart Failure in Nigerian Africans: Insights from the Abeokuta Heart Failure Registry.J Clin Hypert2015; 17(4):263-272

30. Kingue S, Dzudie A, Menanga A, Akono M, Ouankou M, Muna W. A new look at the adult chronic heart failure in Africa in the age of

Doppler echocardiography: experience of the Medicine Department at the Yaoundé General Hospital (in French). Ann Cardiol Angeiol (Paris) 2005; 54:276–283.

31. Bahrami H, Kronmal R, Bluemke DA, Jean Olson, Shea S, Liu K, et al. Differences in the Incidence of Congestive Heart Failure by Ethnicity. The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008; 168(19): 2138–2145.

Downloads

Published

2020-08-04

Issue

Section

Original Articles

How to Cite

Tamaraemumoemi, O., & Johnbull, J. (2020). Prevalence of Prolonged QRS Duration and Associated Factors among Heart Failure Patients in a Tertiary Healthcare Facility in Bayelsa State. Niger Delta Journal of Medical Sciences (NDJMS), 3(1), 7-17. https://ndjms.ndu.edu.ng/index.php/home/article/view/47

Most read articles by the same author(s)